SCHULTZ-EICADA (DO NOT DELETE)

10/7/2016 2:39 PM

“Online Pharmacy Regulation: How
the Ryan Haight Online Pharmacy
Consumer Protection Act Can Help
Solve an International Problem”

BOB SCHULTZ*

TABLE OF CONTENTS
I.
II.

III.

IV.

V.
VI.

INTRODUCTION ........................................................................................ 382
BACKGROUND.......................................................................................... 385
A. Types of Online Pharmacies .......................................................... 385
B. Benefits of Online Pharmacies....................................................... 388
C. Dangers of Some Types of Online Pharmacies .............................. 389
INTERNATIONAL APPROACHES ................................................................. 392
A. World Health Organization ........................................................... 392
B. Internet Healthcare Coalition ........................................................ 394
C. INTERPOL..................................................................................... 395
D. National Association of Boards of Pharmacy ................................ 396
E. Conclusion About International Approaches ................................. 398
UNITED STATES APPROACH ..................................................................... 398
A. Background .................................................................................... 398
B. The Ryan Haight Online Consumer Protection Act of 2008 .......... 399
1. Strengths of the Ryan Haight Act ............................................ 402
2. Weaknesses of the Ryan Haight Act ........................................ 404
C. Conclusions About the Approach of the United States ................... 407
THE CURRENT PROBLEM .......................................................................... 407
MULTINATIONAL REGULATORY SCHEME.................................................. 409

*
© 2015 Bob Schultz. J.D. Candidate, University of San Diego School of Law,
May 2015. Special thanks to Professor Robert C. Fellmeth, Dr. Sidney M. Wolfe, and my
Comments Editor, Brendan O’Connor.

381

SCHULTZ-EICADA (DO NOT DELETE)

VII.
VIII.

10/7/2016 2:39 PM

INTERNATIONAL COMPACT ...................................................................... 410
CONCLUSION ........................................................................................... 414

I. INTRODUCTION
“Love you, Mom.”1 Those were the last words Ryan Haight said to his
mom before he overdosed on a prescription drug he obtained from an
online pharmacy.2 Ryan Haight never even saw the doctor who wrote his
prescription for the drugs.3 Worse yet, the creator of the online pharmacy
and the doctor signing the prescriptions made millions of dollars on their
scheme before Ryan Haight died.4 Although these individuals have been
convicted of applicable crimes,5 the nefarious framework facilitating their
misdeeds remains intact.6
At the time of his death, Ryan Haight’s mother was a registered nurse
and his father was a physician.7 His parents’ professional experience with
prescription medications was one of stringent inventory procedures and
diligent recordkeeping.8 Therefore, they were shocked at how easily their
son had acquired prescription medication and were surprised that online
pharmacies apparently operated with virtually nonexistent standards.9

1. Francine Haight, Presentation, Illegal Sales of Pharmaceuticals on the Internet,
16 ALB. L.J. SCI. & TECH. 565, 566 (2006).
2. Id.
3. Id.
4. Id. at 567; see also DRUG ENFORCEMENT AGENCY, Local Pharmacist and
Stepfather Sentenced in Internet Pharmacy Case (Mar. 17, 2005), http://www.justice.
gov/dea/pubs/states/newsrel/dallas031705.html (noting that the pharmacist involved in
Ryan Haight’s tragedy, Clayton H. Fuchs, made over $8 million dollars operating two
online pharmacies).
5. U.S. v. Fuchs, 467 F.3d 889, 896, 912 n.2 (5th Cir. 2006) (affirming Clayton
Fuchs’s appeal of his conviction on six counts—“includ[ing] conspiracy to dispense a
controlled substance”—following a jury trial and noting that the doctor involved in Ryan
Haight’s tragedy, Robert Ogle, was not a party to the appeal although he had been
convicted on two counts—including “conspiracy to illegally distribute a controlled
substance”—in a jury trial); see also Local Pharmacist and Stepfather Sentenced in
Internet Pharmacy Case, supra note 4.
6. See infra, Part III-C.
7. Haight, supra note 1, at 566.
8. Id. at 566–67.
9. Id.; see also Kristin Yoo, Note, Self-Prescribing Medication: Regulating
Prescription Drug Sales on the Internet, 20 J. MARSHALL J. COMPUTER & INFO. L. 57, 60,
68–69 (2001) (noting that although the NABP has attempted to provide some standards
for online pharmacies, these standards have not affected a vast number of pharmacies
because they are not compulsory).
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Their concerns were not unfounded; according to one report, buying
prescription drugs online can be just as easy as buying candy online.10
There is an unaddressed anomaly with respect to regulating online
pharmacies when compared with traditional pharmacies.11 Online pharmacies
serve the same ends as traditional brick and mortar pharmacies, i.e., to
bring medication to consumers as a part of a profitable business. The
raison d’étre of traditional pharmacy regulation—to protect consumers12
—should logically apply to online sources of the same inherently dangerous
pharmaceuticals. However, traditional pharmacies are regulated, while
online pharmacies have long eluded effective regulation and now constitute
a lawless source of purchase and abuse that is far from real physician
control, effective standards, or accountability.13
Ryan Haight is unfortunately not the only person to have easily obtained
prescription drugs online and subsequently die from, or experience serious
problems associated with, the drugs received.14 Thus, there has been a
diverse call for consumer protection from online pharmacy abuse15 from
consumer advocacy groups, governments, and applicable experts.16
Notwithstanding the fact that many experts recognize the problem,
implementing effective regulations has proven problematic due to inadequacies

10. Joseph A. Califano, Jr., NATIONAL CENTER ON ADDICTION AND SUBSTANCE
ABUSE AT COLUMBIA UNIVERSITY, “You’ve Got Drugs!” Prescription Drug Pushers on
the Internet: 2006 Update (June 2006), http://static.scribd.com/docs/ed89hyvrez48g.swf?
INITIAL_VIEW=width.%20From%20us%20pharmacist%20pdf.
11. See Sean P. Haney, Pharmaceutical Dispensing in the “Wild West”: Advancing
Health Care and Protecting Consumers Through the Regulation of Online Pharmacies,
42 WM & MARY L. REV. 575, 575 (2000).
12. See id. at 587 (noting that a consumer’s “health safety” is at issue when
purchasing from some online pharmacies).
13. See generally id.; see also Barbara J. Williams, Note, On-Line Prescription and
Drug Sales: An Overview of Emerging Issues, 1 HOUS. J. HEALTH L. & POL’Y 147, 148–49
(2001); see also Bryan A. Liang, A Dose of Reality: Promoting Access to Pharmaceuticals,
8 WAKE FOREST INTELL. PROP. L. J. 301, 340 (2008).
14. See Illegal Online Pharmacies Providing Faulty Drugs, FORTHEPEOPLE.COM,
(Oct. 10, 2013), http://www.forthepeople.com/blog/illegal-online-pharmacies-providingfaulty-drugs (noting that many deaths due to overdosing after obtaining prescription drugs
online go unnoticed); see also Williams, supra note 13, at 149.
15. See Jeff Karberg, Note, Progress in the Challenge to Regulate Online
Pharmacies, 23 J.L & HEALTH 113, 114 (2010) (describing a “well documented” need for
more regulation of online pharmacies).
16. Amy J. Oliver, Internet Pharmacies: Regulation of a Growing Industry, 28 J.L
MED. & ETHICS 98, 99 (2000).
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at the national level, coupled with the absence of international controls.17
This inability to effectively regulate is due in large part to the very nature
and characteristics of the internet, including anonymity, instantaneous
communication, jurisdictional obscurity, and the diversity of governing
bodies involved.18 An emboldened representative of an online pharmacy
articulated this difficulty by declaring, “I [do not] think the politicians are
going to be able to do anything to us . . . [it is] kind of like trying to nail
Jell-O to a wall.”19
This problem must be addressed immediately and thoughtfully before
more lives are needlessly ruined or ended. The solution must include an
evolved understanding of not only the reprehensible elements of some
online pharmacy operations, but also the legitimate ends that some online
pharmacies fulfill.20 Also, given the burgeoning international nature of the
internet, an effective solution to this problem can no longer be restricted
to just the nation state, it must be a collaborative international effort with
committed participation from multiple nations.21
Following this introduction, Part II of this Comment will establish a
foundation for analyzing the problem by describing online pharmacies in
the marketplace today. Part III will describe how the international
community has thus far attempted to address the problem of online
pharmacies. Part IV will address how the United States has approached
the problem, including a specific analysis of the strengths and weaknesses
of the Ryan Haight Online Consumer Protection Act of 2008 (“Ryan
Haight Act”). Part V will summarize the current problems still facing the
global marketplace of consumers and citizens. Part VI will recommend a
solution to the problem in the form of an international compact that draws
upon the Ryan Haight Act and international approaches to date. Part VII will
present the objectives and suggested content of such an international
compact.

17. See generally Yoo, supra note 9.
18. Id. at 60; Haney, supra note 11, at 575; see also Kim Zetter, FBI Fears Bitcoin’s
Popularity With Criminals, WIRED (May 9, 2012 at 10:51PM), http://www.wired.com/
threatlevel/2012/05/fbi-fears-bitcoin/ (discussing the potential for bitcoins to facilitate the
sale of illegal products online, largely due to the anonymity it offers purchasers).
19. John Richard Castronova, Operation Cyber Chase and Other Agency Efforts to
Control Internet Drug Trafficking, 27 J. LEGAL MED. 207, 213 (2006).
20. CENTERS FOR DISEASE CONTROL AND PREVENTION, Prescription Drug Overdoses:
An American Epidemic (Feb. 18, 2011), http://www.cdc.gov/about/grand-rounds/archives/
2011/01-February.htm.
21. Jeremy W. Hochberg, Nailing Jell-O to a Wall: Regulating Internet Pharmacies, 37
J. HEALTH L. 445, 468 (2004).
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II. BACKGROUND
A. Types of Online Pharmacies
Not all online pharmacies are the same, and understanding the differences
between the various types illuminates the problems they pose.22 Online
pharmacies are generally classified as a: (1) “traditional online pharmacy,”
(2) “prescribing-based site pharmacy,” or (3) “rogue pharmacy.”23 The
main difference among the pharmacies is the extent to which they require
a prescription or physician-customer interaction. Traditional online
pharmacies require a prescription issued from a customer’s physician;
prescribing-based sites provide a pro forma “cyber-consultation” to
customers and, subsequently, write the prescription for the customer; and
rogue pharmacies do not require a prescription at all before dispensing
prescription drugs.24
Traditional online pharmacies are functionally similar to traditional
brick and mortar pharmacies.25 In fact, these pharmacies are often “an
online extension” of existing well-known brick and mortar pharmacies.26
As such, they require a prescription from a physician before a customer’s
order will be processed and completed.27 This prescription must be
delivered to the pharmacy by the customer or by a physician on behalf of
the customer.28 Because these pharmacies do not prescribe medication
themselves, their function is to simply “provid[e] another medium for one
to fill existing prescriptions.”29
Aside from properly requiring prescriptions, traditional online
pharmacies typically implement rigorous self-imposed standards aimed at
protecting consumers.30 These types of online pharmacies have been

22. David Mills, Cybermedicine: The Benefits and Risks of Purchasing Drugs Over
the Internet, 5 J. TECH. L. & POL’Y 1, para. 5 (2000).
23. Karberg, supra note 15, at 115; Ludmila Bussiki Silva Clifton, Internet Drug
Sales: Is it Time to Welcome “Big Brother” Into Your Medicine Cabinet?, 20 J. CONTEMP.
HEALTH L. & POL’Y 541, 546 (2004).
24. Kerry Toth Rost, Note, Policing the “Wild West” World of Internet Pharmacies”,
76 CHI.-KENT L. REV. 1333, 1334 (2000).
25. Karberg, supra note 15, at 115.
26. Id.
27. Id.
28. Yoo, supra note 9, at 64.
29. Joanna M. Carlini, Note, Liability on the Internet: Prescription Drugs and the
Virtual Pharmacy, 22 WHITTIER L. REV. 157, 171 (2000).
30. Karberg, supra note 15, at 115.
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considered “a valuable addition to the healthcare consumer industry.”31
Accordingly, they are neither part of the online pharmacy problem, nor do
they warrant the implementation of new regulations.32
The second type of online pharmacies, prescribing-based site pharmacies,
presents some problems for consumer safety.33 These pharmacies provide
both the prescription and the medication to customers who visit the site.34
The prescription-writing process usually entails a pharmacy providing the
consumer with a consultation that consists of little more than a
questionnaire.35 Then, a doctor reviews the results of the consultation and, if
approved, the doctor writes the prescription.36 There is no actual physical
examination of the patient in these scenarios, because the entirety of the
“examination” occurs online.37
One obvious problem with these types of pharmacies is that online
questionnaires are simply not comparable to either a thorough medical
history report or to an actual physical examination.38 Patients can, and
often do, provide inaccurate information on these questionnaires, a feat
they would have a harder time accomplishing at a brick-and-mortar
pharmacy during an in-person examination with a doctor or medical
professional.39 Furthermore, these questionnaires do not ask the detailed
or critical questions that are necessary for a proper determination of the
appropriate medication for a particular ailment.40
Another problem with prescribing-based online pharmacies is the high
rate of approval for desired medications, possibly influenced by the fact
that many consulting doctors employed by this type of online pharmacy
get paid by the prescription.41 Furthermore, these types of pharmacies may

31. Rost, supra note 24, at 1334.
32. Bethany Lipman, Note, Prescribing Medicine For Online Pharmacies: An
Assessment of the Law and a Proposal to Combat Illegal Drug Outlets, 50 AM. CRIM. L.
REV. 545, 549 (2013).
33. See Karberg, supra note 15, at 116.
34. Id.
35. See id.
36. Lipman, supra note 32, at 550.
37. Williams, supra note 13, at 151.
38. Mills, supra note 22, at 6.
39. Ann M. Alexander, Buying Drugs over the Internet: Who is Regulating
Pharmacies on the World Wide Web, 13 SYRACUSE SCI. & TECH. L. REP. 1, 3 (2006); see
also Hochberg, supra note 22, at 446 (noting that those with addictions to a pharmaceutical
may go online for the purpose of avoiding the traditional brick-and-mortar physicianpatient interaction).
40. Alexander, supra note 39, at 1.
41. Karberg, supra note 15, at 116; see also Ancier v. State, Dept. of Health, 140
Wash. App. 564, 568 (2007) (where a doctor reviewed 200,000 prescriptions over the
course of three years and approved 180,000 of them); United States v. Fuchs, 467 F.3d
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appear to be legitimate, but the physicians providing the imprimatur are
not acting in accordance with the accepted standards of the medical
profession.42 For instance, one website advertised that it had a licensed
physician reviewing patient questionnaires; however, the website failed to
mention that his license had been revoked in two states.43
The third category, “rogue” online pharmacies, poses additional dangers to
consumers.44 Rogue online pharmacies dispense prescription medications
without first receiving a prescription, offering a questionnaire, or
performing an examination to determine a medical need for the drugs
sought.45 These sites merely require a prospective customer to fill out an
order form and select both the drug and quantity desired.46 In order to
receive the drugs, customers simply pay with a credit card online or
promise to furnish cash when receiving the drugs.47
Rogue online pharmacies generally operate illegally, because only
licensed healthcare practitioners are authorized to dispense pharmaceutical
drugs, and they must do so in accordance with a valid prescription.48
Rogue pharmacies may also operate illegally by selling drugs that are
banned categorically for sale by certain governments.49 As such, they have
been analogized to street drug dealers50 and are widely considered to be
extremely dangerous.51 Nevertheless, this third category of online
pharmacies has proliferated widely.52
There are currently more than “40,000 active rogue [online]
pharmacies.” 53 Adding to public safety concerns, the World Health
Organization (“WHO”) has found that up to 50% of the medicine sold on

889, 898 (5th Cir. 2006) (where one pharmacist received $40 per prescription approved
and another between $40–70 per prescription approved).
42. Lipman, supra note 32, at 550.
43. Williams, supra note 13, at 151.
44. Clifton, supra note 23, at 546.
45. Yoo, supra note 9, at 65.
46. Id.
47. Lipman, supra note 32, at 550.
48. Id.
49. See id.
50. Karberg, supra note 15, at 117.
51. Online Rogue Pharmacies Still Booming, ASSOCIATED PRESS, (Aug. 23, 2007),
http://www.nbcnews.com/id/20409515/#.UmhOiBbvyqQ.
52. Id.
53. Frequently Asked Questions, LEGITSCRIPT, (last visited Mar. 4, 2015) https://
www.legitscript.com/about/faq/.
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these sites is fake.54 This evidences that consumers are in danger of
receiving harmful drugs in addition to failing to receive the drugs they
need.55
Oversight of rogue internet pharmacies is very difficult, as these sites
often diversify the locations of their operations.56 For example, one rogue
pharmacy utilized a domain name registered in Russia, web servers
located in China and Brazil, processed its expenditures through a bank in
Azerbaijan, and shipped its products from India.57 Due to the extreme
risks to patient health posed by “rogue” pharmacies, regulators have,
understandably, largely focused on this “rogue” type of pharmacy.58
B. Benefits of Online Pharmacies
“The beneficial potential of online pharmacies is significant.”59 The
economic incentive to sell pharmaceuticals online is clear. The global
pharmaceutical industry earned over $980 billion dollars in revenue in
2013, up from the $390 billion earned in 2001, and is expected to continue
growing to just under $1.3 trillion by 2017.60 Additionally, over 2.4 billion
of the world’s 7 billion inhabitants are internet users.61 Therefore, because
internet communication costs are essentially negligible, online pharmacies
are an economically attractive proposition to sellers.62
Online pharmacies are not only economically attractive from a seller’s
perspective, but they are also attractive from a buyer’s perspective.63
These sites often offer consumers lower costs due to increased competition64
54. WHO and Partners Accelerate Fight Against Counterfeit Medicines, WORLD
H EALTH O RGANIZATION , http://www.who.int/mediacentre/news/releases/2006/pr69/en/
index.html (last visited Mar. 4, 2015).
55. See id.
56. Yoo, supra note 9, at 66; see, e.g., Liang, supra note 13, at 340 (noting “the
nature of online pharmacies and the inability of key [U.S.] agencies to provide even
rudimentary controls over rogue internet pharmacies”).
57. Internet Pharmacies: Federal Agencies and States Face Challenges Combatting
Rogue Sites, Particularly Those Abroad, GOVERNMENT ACCOUNTABILITY OFFICE (July
2013), http://www.gao.gov/assets/660/655751.pdf.
58. Lipman, supra note 32, at 550.
59. Haney, supra note 11, at 582.
60. Statistics and facts about the pharmaceutical industry worldwide, STATISTA,
http://www.statista.com/topics/1764/global-pharmaceutical-industry/ (last visited Mar. 4,
2015).
61. Internet Users in The World Distribution by World Regions—2012 Q2,
INTERNET WORLD STATS (June 30, 2012), http://www.internetworldstats.com/stats.htm.
62. Clifton, supra note 23, at 541.
63. Rost, supra note 24, at 1337–38; see also Drug Sales Over the Internet, U.S.
FOOD AND DRUG ADMINISTRATION (June 30, 1999), http://www.fda.gov/NewsEvents/
Testimony/ucm115047.htm.
64. Rost, supra note 24, at 1337.
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and lower overhead.65 Consumers may also benefit from comparative
shopping, greater availability of drugs, ease of purchase, and convenience.66
Shoppers also gain the convenience and privacy of ordering drugs online
and having them delivered directly to their doors.67 And, in terms of
legitimate functioning, online pharmacies allow “online prescription
transmission and electronic consults within narrowly defined circumstances,”68
which may not pose a consumer protection issue in certain circumstances.
Considering the benefits that online pharmacies may provide to both
sellers and consumers, it is clear that online pharmacies have the potential
to provide a significant benefit to global society.69 However, with these
tremendous benefits comes a great potential for abuse.
C. Dangers of Some Types of Online Pharmacies
Online pharmacies pose dangers for consumers in many different ways,
as follows:
(a) The illegitimate pharmaceutical industry is growing alongside
the legitimate industry.70
(b) It may be very hard for consumers to distinguish between a
legitimate online pharmacy and an illegitimate or rogue
pharmacy. 71
(c) Consumers have easy access to low-quality, expired, counterfeit, or
unapproved drugs.72
(d) Online pharmacies have begun implementing persistent advertising
strategies in an effort to convince patients to self-diagnose their
medical ailments and purchase drugs they may not need.73

65. Castronova, supra note 19, at 209.
66. Id. at 210.
67. Carlini, supra note 29, at 157.
68. Haney, supra note 11, at 583.
69. Yoo, supra note 9, at 62 (recognizing that “legitimate prescription drug sales
on the internet can provide tremendous benefits to consumers.”).
70. See Counterfeit Medicines, WORLD HEALTH ORGANIZATION (Nov. 14, 2006),
http://www.who.int/medicines/services/counterfeit/impact/ImpactF _S/en/index.html
containing a projection by the Centre for Medicines in the Public Interest that the
worldwide sale of counterfeit pharmaceuticals would be $75 billion in 2010, an increase
of 90% from 2005).
71. Rost, supra note 24, at 1338.
72. Castronova, supra note 19, at 211.
73. Id.
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(e) Consumers are at a greater risk to have their confidential health
information mismanaged and their privacy violated when dealing
with online pharmacies.74
(f) Customers utilizing these sites often believe, incorrectly, that
abusing prescription drugs “cannot be as harmful as abusing
more conventional ‘street’ drugs.”75
(g) Drugs purchased from foreign sites may have incorrect and
dangerous labeling and packaging.76
(h) There may not be a patient-physician relationship.77
The lack of a physician-patient-pharmacist relationship sticks out as
being especially troublesome. Before the emergence of online pharmacies,
prescription drugs were—in the normal course of behavior—not available
without a physician-patient physical interaction.78 Now, prescribingbased and rogue online pharmacies do not require this relationship.79 This
is problematic because, “[n]ot only does the physician have no way of
knowing the identity of his patient, but in many cases the patient has no
way of knowing whether the physician or pharmacist with whom he is
dealing is properly licensed.”80
Further, customers receiving drugs without a physician-patient
consultation or relationship are not afforded the same safeguards provided by
physician and pharmacist reviews.81 Risk is disproportionately allocated
to these consumers, as they are required to learn on their own about the
medication they receive, including proper utilization, potential side
effects, and complications with mixing the medication with other drugs.82
Essentially, “a patient can skip going to the doctor and can substitute a

74. See Karberg, supra note 15, at 132–35.
75. Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act
of 2008; Final Rule, 74 Fed. Reg. 15,595, 15,596 (Apr. 6, 2009) (to be codified at 21
C.F.R. pt 1300, 1301, 1304, et. al.), http://www.gpo.gov/fdsys/pkg/FR-2009-04-06/
html/E9-7698.htm [hereinafter Implementation of the Ryan Haight Act].
76. Michael Veronin, Packaging and Labeling of Pharmaceutical Products
Obtained from the Internet, J. MED. INTERNET. RES. 2011 Jan–Mar. (2011), http://www.
ncbi.nlm.nih.gov/pmc/articles/PMC3221344/ (recognizing that foreign sites are significantly
noncompliant with FDA regulations on the labeling and packaging of pharmaceuticals, a
critical means for patient safety).
77. Mills, supra note 22, at ¶¶ 17, 19.
78. Kara M. Friedman, Internet Prescribing Limitations and Alternatives, 10
ANNALS H. L. 139, 140 (2001).
79. See Rost, supra note 24, at 1334.
80. Hochberg, supra note 21, at 452.
81. Rost, supra note 24, at 1339.
82. Id.
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click of the button for 6 years of medical school”83 and additional years
of residency training.
The following two examples vividly illustrate some of the most
troublesome characteristics of online pharmacies, particularly the ease
with which drugs may be obtained and the alarming lack of oversight.
These examples would almost be comical were the life and death
implications not so glaringly apparent.
First, an investigative journalist successfully obtained weight loss
medication from an online pharmacy by inputting the information of a
seven-year-old child into the website.84 Secondly, another investigative
journalist obtained Viagra for her cat from an online pharmacy. 85 This
journalist simply filled out a questionnaire with the cat’s information,
including its exact height (six inches tall) and weight (fifteen pounds).86
Further, in response to a question about prior surgeries, the journalist
responded, “Neutered, 12/15/88.”87
Not only did the pharmacies in these examples fill and deliver such
ludicrous prescriptions, but they also did not question any of the inputted
data.88 This suggests neither a physician nor a pharmacist ever reviewed
these orders in any meaningful sense.89 The nonsensical and glaring
failures that these two examples exemplify are disconcerting.90
The negative effects of some online pharmacies are substantial, as
evidenced by the vast number of people who are getting sick or dying due
to medications obtained through these types of pharmacies.91 Action must
be taken to improve the landscape of providing medication online,
particularly international regulation, as national regulatory regimes
inherently fall short of realizing a lasting solution due to the glaring holes
in the regulatory schemes.92

83.
84.
85.
86.
87.
88.

Carlini, supra note 29, at 173.
Castronova, supra note 19, at 207.
Id.
Williams, supra note 13, at 153.
Carlini, supra note 29, at 159.
Consumer News, Congressional Panel Discusses Online Pharmacies, 11 LOY.
CONSUMER L. REV. 212, 213 (1999).
89. Carlini, supra note 29, at 159.
90. See generally id.
91. WHO and Partners Accelerate Fight Against Counterfeit Medicines, supra note
54.
92. Haney, supra note 11, at 612.
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III. INTERNATIONAL APPROACHES
Many scholars and health organizations have called for a comprehensive,
unified international approach to regulating online pharmacies, including
establishing “standardized regulations, operations, and reporting
infrastructures supported by serious criminal penalties.”93 Nevertheless,
international approaches to solving the problem of regulating online
pharmacies have thus far, at best, provided short-term relief, not a lasting
solution.
A. World Health Organization
The WHO has explicitly recognized the potential for selling prescription
drugs online to evade unilateral regulatory regimes and has noted that this
poses a problem for consumers worldwide because it makes medical
products that are “unapproved, fraudulent, unsafe, or ineffective” readily
available.94 In accordance with this recognition, the WHO has dedicated
resources to address this problem beginning as early as 1997.95
For example, at the request of the Fiftieth World Health Assembly, the
WHO created a group to gather information pertaining to the problems
associated with online pharmacies.96 This group collected data by
collaborating with “drug regulatory agencies, national and international
enforcement agencies, consumer groups, professional associations, and
the pharmaceutical industry.”97 Subsequently, at the request of the FiftyFirst World Health Assembly, the WHO investigated relevant “existing
legislation, regulation, and guidelines.”98
Thereafter, in a further effort to better understand how countries
regulate the buying and selling of prescription medications online, the
WHO sent a questionnaire to all 191 of its Member States and received
responses from 58.99 The results of the questionnaire “give good grounds
for safety concerns.”100 The WHO received information that only five

93. See, e.g., Brian A. Liang, Fade to Black: Importation and Counterfeit Drugs,
32 AM. J. L. & MED. 279, 312 (2006).
94. Brian A. Liang & Tim Mackey, Searching for Safety: Addressing Search
Engine, Website, and Provider Accountability for Illicit Online Drug Sales, 35 AM. J. L.
& MED. 125, 141 (2009).
95. Id.
96. Dr. Lembit Rägo, Overview of activities by the World Health Organization,
WORLD HEALTH ORGANIZATION 7 (Sept. 24–25, 2001) http://apps.who.int/medicinedocs/
pdf/h2960e/h2960e.pdf.
97. Id.
98. Id.
99. Id. at 7–8.
100. Id. at 8.
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countries “specifically regulate the promotion and sale of pharmaceuticals
through the internet.”101
The apparent dearth of national solutions evinced by this questionnaire,
coupled with the other relevant data the WHO had previously obtained,
resulted in the WHO’s attempt to provide Member States with templates
capable of being implemented locally.102 These templates include an
informational guidebook and a draft website for drug regulatory
authorities.103
Specifically, the WHO guidebook, entitled Medical Products and the
Internet: A Guide to Finding Reliable Information, serves as an
educational tool for nations to present to their citizens.104 The guidebook
seeks to educate consumers on a variety of topics, including being able to
locate warning signs on online pharmacies, such as: (1) advertisements
that claim scientific breakthroughs, (2) advertisements claiming to be the
exclusive source for a drug (and that it can only do so for a limited time),
and (3) statements that the drugs pose no risks whatsoever.105 The
guidebook also includes a top-ten list of how prescription drugs can be
dangerous and ways consumers can spot a legitimate online pharmacy.106
This list includes tips about what to look for, including active ingredients,
instructions on proper use, and warnings about possible negative side
effects.107
The WHO has also endeavored to educate consumers worldwide about
purchasing drugs online via its cooperation with the International
Conference of Drug Regulatory Agencies (“ICDRA”).108 ICDRA
conferences provide a forum for the regulatory bodies of the WHO
Member States to share information and collaborate with one another

101. Id.
102. Id.
103. Id.
104. Ivette P. Gomez, Note, Beyond the Neighborhood Drug Store: U.S. Regulation
of Online Prescription Drug Sales by Foreign Business, 28 RUTGERS COMPUTER & TECH.
L.J. 431, 454–55 (2002).
105. Id. at 455.
106. Id.
107. Id.
108. Liang & Mackey, supra note 94, at 143.
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about how to regulate online pharmacies.109 The goal of these conferences
is ultimately to harmonize regulations.110
The WHO has taken more directed action through the WHO International
Medical Products Anti-Counterfeiting Taskforce (“IMPACT”).111 IMPACT
“aims to build coordinated networks across and between countries in order
to halt the production, trading, and selling of fake medicines around the
globe.”112 Comprised of “international organizations, non-governmental
organizations, enforcement agencies, pharmaceutical manufacturers
associations, and drug and regulatory agencies,” IMPACT recognizes the
need for “an international multi-stakeholder” coordinated approach to
solve these problems and protect consumers.113 IMPACT presents “guiding
principles for model legislation” to help countries better align their laws
with the policy of punishing or deterring this activity.114
B. Internet Healthcare Coalition
Another international organization that has attempted to combat the
negative effects of online pharmacies is the Internet Healthcare Coalition
(“IHC”).115 The IHC is an international non-profit organization that consults
with many government agencies and holds a yearly conference to discuss
the problems regarding, inter alia, providing prescription medications
online.116 The specific aims of the organization are to: 1) educate parties
involved in healthcare about providing healthcare online, 2) provide
“models . . . of good and bad sources of online healthcare information and
services,” 3) promote pre-existing resources and create new resources
pertaining to providing healthcare online, and 4) serve “as a
representative . . . before public policymakers and with the media.”117 The
IHC has become a “global leader” in educating people about using the
internet for healthcare purposes.118
109. International Conference of Drug Regulatory Authorities, WORLD HEALTH
ORGANIZATION, http://www.who.int/medicines/areas/quality_safety/regulation_legislation/icdra/
en/.
110. Id.
111. Liang & Mackey, supra note 94, at 143.
112. About Us, INTERNATIONAL MEDICAL PRODUCTS ANTI-COUNTERFEITING TASKFORCE,
http://www.who.int/impact/about/en/.
113. Id.
114. WHO and Partners Accelerate Fight Against Counterfeit Medicines, supra note
54.
115. Gomez, supra note 104, at 456.
116. John Mack, The Internet Healthcare Coalition, U.S. NATIONAL LIBRARY OF
MEDICINE NATIONAL INSTITUTES OF HEALTH (Mar. 5, 2000), http://www.ncbi.nlm.nih.
gov/pmc/articles/PMC1761844/.
117. Id.
118. Gomez, supra note 104, at 457.
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In 2000, the IHC partnered with other organizations to formulate the “eHealth Ethics Initiative” (“the Initiative”).119 The purpose of the Initiative
was to “creat[e] a universal ethical code of conduct for health and medical
websites.”120 The Initiative aimed to enable consumers to make better and
more informed decisions by generating information that would help
consumers understand the statements online pharmacies present on their
websites.121
C. INTERPOL
INTERPOL has also recognized the problems of illicit online pharmacies
and has created many task forces aimed at the enforcement of crimes,
global education, and cooperation.122 For instance, one of INTERPOL’s
flagship operations, Operation Pangea, is dedicated to targeting and
intervening against the sale of illegal drugs online.123 The operation conducts
one mission annually consisting of a week of coordinated efforts among
“customs, health regulators, national police, and the private sector.”124
Operation Pangea achieves its success by targeting the following: “internet
service providers, payment systems, and the delivery service” utilized by
illegal online pharmacies.125
Although only ten countries participated in the operation’s inaugural
year, 2008, the most recent phase in 2013 brought together about 100
countries.126 There have been six phases of Operation Pangea to date and,
collectively, they have identified and shut down a great number of
websites engaged in illegal activity and have resulted in multiple arrests
of those affiliated with the sale of illegal drugs online.127
In the most recent phase of Operation Pangea, Pangea VI, INTERPOL
confiscated 10.1 million illicit and counterfeit pills worth about $36

119.
120.
121.
122.

Id.
Id.
Id.
See Judy Siegel-Itzkovich, Global Crackdown on Illicit Online Pharmacies,
PERMANENT FORUM ON INT’L PHARMACEUTICAL CRIME (July 2, 2014), http://pfipc.org/news1/9global-crackdown-on-illicit-online-pharmacies.
123. Operations, INTERPOL, http://www.interpol.int/Crime-areas/Pharmaceutical-crime/
Operations/Operation-Pangea (last visited Jan. 13, 2013).
124. Id.
125. Id.
126. Id.
127. See id. (providing information about each Operation Pangaea mission to date).
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million dollars, destroyed over 13,700 websites, either investigated or
arrested about 213 individuals, and inspected over 500,000 packages,
resulting in the confiscation of 41,000.128 Major market players were
involved in Pangea VI, including the United States, the United Kingdom,
China, India, Japan, and Canada.129
In addition to Operation Pangea, INTERPOL has recently established
another unit, the Medical Products Counterfeiting and Pharmaceutical
Crime unit (“MPCPC”), which is designed to engage in the international
enforcement of illicit online pharmacies.130 This unit was created to
support WHO-IMPACT in combatting online pharmaceutical crime.131
D. National Association of Boards of Pharmacy
There are also smaller organizations dedicated to educating consumers
about illegal online pharmacies.132 One such organization is the National
Association of Boards of Pharmacy (“NABP”).133 The NABP has been
active in addressing the problems associated with online pharmacies. For
instance, the NABP maintains a database with information about pharmacies
and pharmacists.134 Additionally, the NABP hosts a global certification
program—Verified Internet Pharmacy Practice Site (“VIPPS”)—that
verifies online pharmacies as being legitimate.135 The purpose of the VIPPS
program is to put consumers on notice that an online pharmacy with a
VIPPS certification has passed an independent inspection.136
This VIPPS program was established due to mounting public concern
about the problems online pharmacies may pose to consumers, and it
allows online pharmacies to boast a seal of approval on their website, should
they satisfy the VIPPS requirements. 137 These requirements include
“compliance with standards of privacy and authentication and security of

128. Id.
129. International Operation Targets Online Sale of Illicit Medicines, INTERPOL
(June 27, 2013), http://www.interpol.int/News-and-media/News-media-releases/2013/PR077
(last visited Jan. 13, 2014).
130. INTERPOL applauds Southeast Asia Operation Storm II’s Success in Disrupting
Trade of Counterfeit Medical Products, INTERPOL (Jan. 27, 2010), http://www.interpol.
int/News-and-media/News-media-releases/2010/PR007.
131. Id.
132. See, e.g., Who We Are, ALLIANCE FOR SAFE ONLINE PHARMACIES, http://safeonlinerx.
com/about-us/who-we-are/ (last visited Jan. 13, 2014).
133. See About, NATIONAL ASSOCIATION OF BOARDS OF PHARMACY, http://www.
nabp.net/about (last visited Jan. 13, 2014).
134. Williams, supra note 13, at 181.
135. Id. at 181–82.
136. Castronova, supra note 19, at 220.
137. Oliver, supra note 16, at 99.
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prescriptions, adhere[nce] to quality assurance policy, and provid[ing]
meaningful consultation between patients and pharmacists.”138
Currently, there are thirty-five VIPPS certified pharmacies, eleven of
which require membership in order to obtain medication, while the
remaining twenty-four are open to all customers.139 Although this program
was the first attempt to establish a set of minimum standards for the online
pharmacy industry, its effect has not been very successful, because
participation is voluntary140 and stricter regulation is needed.141
The NABP is also responsible for a more recent development in the
international approach to regulating online pharmacies.142 The NABP
proposed to establish and become the official registry for a new domain
name for buying pharmaceutical medications online, so that consumers
can be confident in the safety of the drugs they are obtaining.143 NABP
promulgated this suggestion at the 2013 International Pharmacy
Federation World Congress, where it further explained the uniform
domain—“.PHARMACY.”144 The uniform domain would ensure that
accepted pharmacies “meet all the applicable regulatory standards . . . in
the jurisdictions where they are based and where they serve patients.”145
These oversight standards would include “pharmacy licensure, drug
authenticity, and valid prescription requirements.”146
However, this proposal has faced a strong opposition that seeks to
prevent it from being implemented.147 Among the opponents to NABP
138. VIPPS, NATIONAL ASSOCIATION OF BOARDS OF PHARMACY, http://www.nabp.
net/programs/accreditation/vipps (last visited Jan. 13, 2014).
139. Find a VIPPS Pharmacy Online, NATIONAL ASSOCIATION OF BOARDS OF
PHARMACY, http://www.nabp.net/programs/accreditation/vipps/find-a-vipps-online-pharmacy/
(last visited Jan. 13, 2014).
140. Yoo, supra note 9, at 69.
141. Alexander, supra note 39.
142. See NABP Shares Online Pharmacy Safety Information at International
Pharmaceutical Federation World Congress, NATIONAL ASSOCIATION OF BOARDS OF
PHARMACY (Sept. 18, 2013 5:40 PM), https://www.nabp.net/news/nabp-shares-onlinepharmacy-safety-information-at-international-pharmaceutical-federation-world-congress.
143. Id.
144. Id.
145. .PHARMACY and NABP, NATIONAL ASSOCIATION OF BOARDS OF PHARMACY,
http://www.nabp.net/programs/pharamcy/pharmacy-and-nabp (last visited Jan. 13, 2014).
146. Id.
147. See, e.g., Public Citizen, Demand Progress and RXRights.org Join Others
Opposing U.S. Pharmacy Industry Group From Controlling “Pharmacy” Domain Registration,
PRWEB (May 30, 2013), http://www.prweb.com/releases/oppose/NABP-ICANN/prweb
10780126.htm.
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controlling the “.PHARMACY” domain are Public Citizen, Demand
Progress, and RxRights.org.148 These opponents of NABP’s proposal
claim the operation will sacrifice consumer access to affordable medication
in order to benefit pharmaceutical companies.149
E. Conclusion About International Approaches
Although these aforementioned international approaches have seen
some success, they have not had lasting effects on the online pharmacy
industry. The problem requires more than education campaigns and short
bursts of sporadic enforcement. Without re-directed efforts, there are still
too many avenues for online pharmacies to exploit.
IV. UNITED STATES APPROACH
A. Background
The United States presents a domestic regulatory scheme illustrative of
a unilateral, national approach to regulating online pharmacies. Traditionally,
each state individually regulates pharmacies.150 However, online pharmacies
are regulated largely by the Food and Drug Administration (“FDA”) and
the Drug Enforcement Administration (“DEA”).151 The FDA regulates
online pharmacies through the Federal Food, Drug, and Cosmetic Act
(“FDCA”), while the DEA regulates online pharmacies through the
Controlled Substances Act (“CSA”).152 Although the two agencies often
work together, the FDA focuses on what has been categorized as “noncontrolled substances”, while the DEA focuses on what has been categorized
as “controlled substances.”153
With this infrastructure in place, the distribution of prescription drugs
in the United States has been “one of the safest systems in the world.”154
However, with the emergence of online pharmacies, the United States has
been forced to change its model and adapt its regulations to accommodate

148. Id.
149. Id.
150. Oliver, supra note 16, at 99.
151. Karberg, supra note 15, at 118.
152. Id.
153. Id.
154. Clifton, supra note 23, at 544; but cf. Geoffrey Kabat, Natural Does Not Mean Safe,
SLATE, http://www.slate.com/articles/health_and_science/medical_examiner/2012/11/herbal_
supplement_dangers_fda_does_not_regulate_supplements_and_they_can.1.html (last visited
Jan. 17, 2014) (recognizing that there are still problems with such regulations, including
the health risks associated with the exemptions from FDA regulation afforded to “dietary
and herbal supplements”).
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the benefits of online pharmacies, while also attempting to eliminate the
harms.155
One way in which the DEA has attempted to combat illicit online
pharmacies was by creating a database named the Automation of Reports
and Consolidated Orders System (“ARCOS”).156 This program requires
manufacturers and distributors of pharmaceuticals to provide the DEA
with information about narcotic substances.157 The goal is to allow the
DEA to utilize this data to pursue investigative leads where consumers
were purchasing abnormally high volumes of controlled substances.158
Furthermore, the DEA implemented the “Internet Distributor Initiative”
and the “Internet Industry Initiative” in an attempt to make distributors
accountable for their misdeeds and raise awareness among other parties
who are involved in the misdeeds, including delivery services and credit
card companies.159
These initiatives may have brought about some success.160 A study
performed by the National Center on Addiction and Substance Abuse at
Columbia University indicated that rogue internet pharmacies decreased
25% from 2004 to 2008.161 However, a regulatory framework was needed
to further combat online pharmacies, and that need that was realized in
2008 with the passage of the Ryan Haight Online Consumer Protection
Act of 2008.
B. The Ryan Haight Online Consumer Protection Act of 2008
Ryan Haight’s story motivated Congress to amend the Controlled
Substances Act (“CSA”) by passing the Ryan Haight Online Pharmacy
Consumer Protection Act of 2008 (“Ryan Haight Act”).162 This piece of
legislation is essentially the first in the United States to specifically attack
the problem of online pharmacies.163 The act explicitly prohibits distributing

155. See generally Kabat, supra note 154, at 544.
156. Monica Kim Sham, Note, Down on the Pharm: The Juvenile Prescription Drug
Abuse Epidemic and the Necessity of Holding Parents Criminally Liable for Making Drugs
Accessible in Their Homes, 27 J. CONTEMP. HEALTH L. & POL’Y 426, 440 (2011).
157. Id.
158. Id.
159. Id.
160. Id. at 440–41.
161. Id.
162. See Karberg, supra note 15, at 114, 122.
163. Id. at 122.
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controlled substances online without a doctor-patient physical examination.164
Accordingly, the online pharmacies that already require a doctor-patient
examination—the traditional online pharmacies—are not targeted, while
prescribing-based and rogue pharmacies are the subject of the Act.165 The
purpose of the Ryan Haight Act has been described as a means “to protect
consumers by ensuring that only legitimate, law-abiding Web sites dispense
controlled substances via the Internet.”166
The Ryan Haight Act specifically states, “[n]o controlled substance that
is a prescription drug as determined under the Federal Food, Drug, and
Cosmetic Act may be delivered, distributed, or dispensed by means of the
internet without a valid prescription.”167 A valid prescription is defined as
“a prescription that is issued for a legitimate medical purpose in the course
of professional practice by—(i) a practitioner who has conducted at least
1 in-person medical evaluation of the patient; or (ii) a covering
practitioner.”168 A covering practitioner is one who:
conducts a medical evaluation (other than an in-person medical evaluation) at the
request of a practitioner who—(i) has conducted at least 1 in-person medical
evaluation of the patient or an evaluation of the patient through the practice of
telemedicine within the previous 24 months; and (ii) is temporarily unavailable
to conduct the evaluation of the patient.169

Moreover, the Ryan Haight Act mandates a new DEA registration for
online pharmacies.170 This registration allows the DEA to better recognize
and keep track of the misdeeds of online pharmacies.171
Not only must an online pharmacy now register with the DEA in order
to operate legally, but it must also report the amount of controlled substances
it distributes, by any means, during a given month, if the amount it has
distributed is above the given threshold requirements.172 The threshold
requirements are as follows: “(A) 100 or more prescriptions dispensed.
(B) 5,000 or more dosage units of all controlled substances combined.”173
164. Lipman, supra note 32, at 552; Controlled Substances Act (CSA), 21 U.S.C. §
829(e)(2)(A)(i) (2012).
165.
See Sarah Rubenstein, New Bill Targets Rogue Druggists on the Internet,
WALL ST. J. (Oct. 9, 2008 12:01 AM), http://online.wsj.com/news/articles/SB12235152
1815117817.
166. Implementation of the Ryan Haight Act, supra note 75, at 15,609.
167. 21 U.S.C. § 829(e)(1).
168. 21 U.S.C. § 829(e)(2)(A).
169. 21 U.S.C. § 829(e)(2)(C).
170. Implementation of the Ryan Haight Act, supra note 75, at 15,599; see also
Karberg, supra note 15, at 124–25.
171. Karberg, supra note 15, at 124–25.
172. Implementation of the Ryan Haight Act, supra note 75, at 15,601; 21 U.S.C. §
827(d)(2).
173. 21 U.S.C. § 827(d)(2)(A); 21 U.S.C. § 827(d)(2)(B).
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The Ryan Haight Act also requires an online pharmacy to display
specific information about its operations on its website.174 First, the online
pharmacy must post a statement and declaration of compliance with the
new regulations.175 Second, the online pharmacy must prominently display
the following information: “[t]he name and address of the pharmacy, [t]he
pharmacy’s telephone number and email address,” the qualifications and
contact information of the pharmacist in charge, “[a] list of the states in
which the pharmacy is licensed to dispense controlled substances,” a
certificate of registration to distribute controlled substances, the qualifications
and contract information of the person who will provide medical evaluations
or issue prescriptions for controlled substances, and a statement of
notice.176
The Ryan Haight Act also adds two new crimes to the existing CSA
regulatory framework.177 Specifically, the Ryan Haight Act provides that,
“[i]t shall be unlawful for any person to knowingly or intentionally—(A)
deliver, distribute, or dispense a controlled substance by means of the
internet, except as authorized by this subchapter; or (B) aid or abet . . . any
activity described in subparagraph (A) that is not authorized by this
subchapter.”178
The Ryan Haight Act also broadens the civil liability for violations by
allowing states to bring a civil action in federal court.179 Specifically, the
Act provides, “[i]n any case in which the State has reason to believe that
an interest of the residents of that State has been or is being threatened or
adversely affected by the action of [sic] [an] Internet site” may bring an
action in a federal district court.180 Relief in these instances is not limited
to equitable damages; legal damages are also available.181
The DEA attempted to articulate, in a press conference, the most
important features of the Ryan Haight Act as: 1) requiring at least one
face-to-face medical examination between a patient and a doctor a prescription
174. Implementation of the Ryan Haight Act, supra note 75, at 15,602–03; 21 U.S.C.
§ 831.
175. 21 U.S.C. § 831(a); 21 U.S.C. § 831(e).
176. 21 U.S.C. § 831(c).
177. Implementation of the Ryan Haight Act, supra note 75, at 15,602–03; 21 U.S.C.
§ 841(h) (2010).
178. 21 U.S.C. § 841(h).
179. Implementation of the Ryan Haight Act, supra note 75, at 15,602; 21 U.S.C. §
882(c) (2009).
180. 21 U.S.C. § 882(c).
181. See id.
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for a controlled substance to be valid, 2) requiring a DEA endorsement
before an online pharmacy may distribute controlled substances online, 3)
deterring the sale of certain drugs by increasing the penalties associated
with selling such drugs, 4) prohibiting advertising the illegal sale of
controlled substances online, 5) requiring an online pharmacy to post
truthful information about its operation, and 6) allowing a civil state cause
of action for state attorney generals.182
1. Strengths of the Ryan Haight Act
The Ryan Haight Act is not a perfect example of domestic regulation;
nevertheless, there are some merits in its approach to regulating online
pharmacies, as it embraces the right policies and is capable of serving as
a good model for expansion.183 Although still new in its implementation,
the Ryan Haight Act has been recognized as having had a significant
impact on reducing the number of domestic online pharmacies operating
illegally.184 Specifically, the Ryan Haight Act has had the greatest influence
on combatting prescribing-based online pharmacies, both through prosecutions
for noncompliance and through the deterrent effect it has, because of the
clear message it sends to operators of online pharmacies about what is and
is not legal.185 In fact, five years after the Ryan Haight Act passed,
prescribing-based online pharmacies have been “largely eliminated” in
the United States.186
Arguably the most prominent strength of the Ryan Haight Act is that it
requires online pharmacies to obtain a valid prescription in order to
distribute drugs, which must consist of at least one face-to-face doctorpatient interaction.187 This requirement, at least in theory, puts an end to
prescribing-based and “rogue” online pharmacies188 and has led to the
government prosecuting the operators of such pharmacies.189 Unfortunately,
although this new requirement is necessary for compliance, it is not

182. Congress Passes Ryan Haight Online Consumer Protection Act, DRUG
ENFORCEMENT AGENCY (Oct. 1, 2008), http://www.justice.gov/dea/pubs/pressrel/pr100
108.html.
183. Drug Dealers on the Internet: Is the DEA enforcing the Ryan Haight Act?,
LEGITSCRIPT (June 2011), http://www.legitscript.com/download/LegitScript-DEA-RogueInternet-Pharmacy-Analysis.pdf (noting that the DEA has not effectively enforced the
Ryan Haight Act).
184. National Drug Control Strategy, OFFICE OF NATIONAL DRUG CONTROL POLICY
(2010), http://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/ndcs2010.pdf.
185. Lipman, supra note 32, at 553.
186. Id.
187. See Karberg, supra note 15, at 126; 21 U.S.C. § 829 (2009).
188. Karberg, supra note 15, at 126.
189. Lipman, supra note 32, at 553.
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sufficient because other regulations must be adhered to as well, such as
the mandate that controlled substances “be issued for a legitimate medical
purpose by an individual practitioner acting in the usual course of his
professional practice.”190
Another strength of the Ryan Haight Act is the requirement that online
pharmacies register with the DEA, in order to be authorized to dispense
controlled substances online.191 Such a requirement was previously in
place for traditional brick-and-mortar pharmacies, and this new requirement
helps put online pharmacies on “equal footing” with these traditional
pharmacies.192 Now, unregistered sites are illegal and, thus, the DEA can
shut down any unregistered site and pursue both criminal and civil legal
action.193
A beneficial corollary of this registration requirement is that it can
simultaneously act as a database for legitimate online pharmacies.194 In
fact, one commentator has suggested that a list of DEA registered online
pharmacies can set “the foundation for cooperation with other government
agencies and business entities while also educating consumers as to the
legitimacy of the pharmacies they visit online.”195
Additionally, the Ryan Haight Act’s requirement that each site discloses
certain information about its operations is a very effective means of educating
consumers about the legality of the drugs they purchase online.196 The
disclosure is effective, in part, due to the requirement that the information
be conspicuously posted.197
Another strength of the Ryan Haight Act is the notice it gives to
operators of online pharmacies, physicians, and pharmacists: all pharmacies,
whether operating online or out of a storefront, are now going to be held
to the same standards.198 The Ryan Haight Act does this by setting a
standard “baseline professional conduct” for doctors and pharmacists
190. Implementation of the Ryan Haight Act, supra note 76, at 15,599 (referring to
21 CFR 1306.04(a)).
191. Karberg, supra note 15, at 123–25.
192. Id. at 123
193. Id. at 125; see also Implementation of the Ryan Haight Act, supra note 75, at
15,599.
194. Karberg, supra note 15, at 125.
195. Id.
196. Id. at 125–26.
197. Id. at 126.
198. Implementation of the Ryan Haight Act, supra note 75, at 15,609–10; see also
Karberg, supra note 15, at 125–26.
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participating in the online pharmacy market.199 This notice applies not
only to the individuals who knowingly have been operating illegal sites,
but also to those who were under the impression that their online
prescribing or distribution practices were legitimate.200 Accordingly, all
involved in the online pharmacy market can no longer expect the disparate
treatment online pharmacies had been receiving as compared with brickand-mortar pharmacies, and they are effectively on notice that the United
States has recognized the problems associated with illicit online
pharmacies and has implemented more stringent regulations in response
to those problems.
The Ryan Haight Act also features an increase in the severity of
punishments for violations of the CSA.201 Violators of the Ryan Haight
Act face criminal penalties that could be double what they were prior to
the passage of the Ryan Haight Act.202 Furthermore, the Ryan Haight Act
broadened the scope of civil liability by allowing states to bring a civil
action on behalf of their citizens if they believe the citizens of their state
are being negatively affected by an online pharmacy.203 Remedies
available under such a suit include legal damages and equitable relief.204
These added penalties are beneficial, as they may deter illicit online
pharmacy operators or preclude them from continuing their operations or
starting new ones.
2. Weaknesses of the Ryan Haight Act
Despite its apparent successes, the Ryan Haight Act is not a comprehensive
safeguard. Its scope is too narrow in addressing only “controlled substances,”
a small fraction of prescriptions dispensed in the United States.205 This
confined scope also leaves a gap in consumer protection, vis-a-vis foreign
pharmacies, and does not protect patient privacy.206
Non-controlled substances also pose dangers for consumers.207 Noncontrolled substances include a wide variety of prescription drugs, from
the erectile dysfunction drugs Viagra and Cialis, to the painkiller Celebrex,

199. Karberg, supra note 15, at 126.
200. Lipman, supra note 32, at 553.
201. Karberg, supra note 15, at 122–23; see also Congress Passes Ryan Haight
Online Consumer Protection Act, supra note 182.
202. See Congress Passes Ryan Haight Online Consumer Protection Act, supra note
182.
203. 21 U.S.C. § 882 (2013).
204. Karberg, supra note 15, at 128.
205. Id. at 131–32.
206. Id.
207. Id. at 131.
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and the muscle relaxant Soma.208 Unfortunately, online pharmacies target
these and other excluded drugs.209 In particular, drugs with weight-loss or
erectile dysfunction appeal are internet marketed for the supposed “privacy”
of the transaction.210 Future regulations must also address non-controlled
substances, because they pose some of the same quality concerns as many
controlled substances and are potentially harmful.211
The same two senators who introduced the Ryan Haight Act to
Congress, Dianne Feinstein and Jeff Sessions, have voiced their concern
about the Act’s insufficient scope in Congress.212 These senators have
unsuccessfully called for the passage of the Online Pharmacy Safety Act
of 2011,213 which essentially would have broadened the scope of the Ryan
Haight Act to include regulation of all prescription drugs instead of
merely addressing non-controlled substances.214 The bill also called for an
amendment to the FDCA and participation from the Secretary of Health
and Human Services and the FDA in administering the law.215
The most serious failure of the Ryan Haight Act is its inability to
address foreign-based rogue online pharmacies.216 These foreign-based
rogue sites are the principle offender in the realm of online pharmacies,
yet the Ryan Haight Act essentially does not address them.217 Not only
does the Ryan Haight Act not address foreign pharmacies, its effectiveness
in so doing would be suspect had it attempted to do so.218
Foreign pharmacies are elusive by their very nature, as they are not
subject to domestic laws.219 Therefore, the Ryan Haight Act, being that it
208. Sarah Rubenstein, New Bill Targets Rogue Druggists on the Internet, WALL ST.
J. (Oct. 9, 2008), http://online.wsj.com/news/articles/SB122351521815117817.
209. See Karberg, supra note 15, at 138.
210. Id.
211. See id.
212. See Dianne Feinstein, Sessions Call for Stricter Online Pharmacy Rules,
FEINSTEIN.SENATE.GOV (Dec. 15, 2011), http://www.feinstein.senate.gov/public/index.cfm/
press-releases?ID=9ac81372-466a-49e1-9d04-33da43cdb806.
213. See S. 2002 (112th): Online Pharmacy Safety Act, GOVTRACK.US (2011), https://
www.govtrack.us/congress/bills/112/s2002#overview (indicating this bill has died in
committee and is not currently under review by Congress).
214. Feinstein, supra note 212.
215. Online Pharmacy Safety Act, H.R. 4095, 112th Cong. (2012), http://beta.congress.
gov/bill/112th/house-bill/4095.
216. Lipman, supra note 32, at 553.
217. Liang & Mackey, supra note 94, at 152.
218. See generally id.
219. See Karberg, supra note 15, at 135; see also Liang & Mackey, supra note 94,
at 150.
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is a domestic piece of legislation, implicitly has a substantial territorial
application restriction.220 To enforce such domestic legislation, the United
States—and any other country for that matter—has little authority
internationally, other than to request foreign governments get involved.221
This may be difficult to achieve, as it is possible for a pharmacy to be in
compliance with the laws of the foreign government in which it has based
its operations, even if it does not comply with American regulations.222
Essentially the only impact the Ryan Haight Act has on foreign-based
rogue internet pharmacies is that there are steeper penalties for
distributing certain medications.223 However, this impact is greatly
minimized by the fact that operators of these sites know the likelihood of
being caught and prosecuted for their behavior is minimal.224 This is
evidenced by the fact that nearly 97% of online pharmacies are still
operating in non-compliance with state and federal laws or industry
standards.225
The Ryan Haight Act also fails to establish standards that protect patient
privacy.226 “Identity theft, fraud, and patient privacy” are concerns for any
internet transaction227 and these concerns are amplified when dealing with
sensitive information like medical records.228 Thus, the legislature omitted
what should be a necessary component of any regulation in this area when
it failed to address patient privacy in the Ryan Haight Act.229
Rather than protecting consumers, it has also been argued that the “valid
prescription” requirement provides illicit online pharmacies with another
opportunity to exploit users.230 As the argument goes, illicit online pharmacies
may utilize the “valid prescription” requirement as another opportunity to
charge their customers and collect more money from them.231
These problems should make American lawmakers realize that effectively
regulating online pharmacies is an “inherently international crime problem.”232

220. See Karberg, supra note 15, at 135; see also Liang & Mackey, supra note 94,
at 150.
221. Liang & Mackey, supra note 94, at 150.
222. Phil Ayers, Prescribing a Cure for Online Pharmacies, 72 TENN. L. REV. 949,
976 (2005).
223. Lipman, supra note 32, at 554.
224. Id.
225. Id. at 560–61.
226. Karberg, supra note 15, at 132.
227. Id.
228. Id.
229. See id.
230. Liang & Mackey, supra note 94, at 152.
231. Id.
232. Lipman, supra note 32, at 563.
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C. Conclusions About the Approach of the United States
The Ryan Haight Act has been considered “a much needed first step
toward meaningful regulation of online pharmacies.”233 Pharmacies in the
international community could potentially benefit by applying some of the
underlying principles behind the Ryan Haight Act to continue moving in
the right direction toward solving the worldwide crisis of online pharmacy
regulation.
V. THE CURRENT PROBLEM
As illustrated by the United States’ legislation aimed at regulating
online pharmacies and the international approaches to doing the same,
there exists a deficiency in effective regulation. Domestic regulations fall
short, as sovereign States do not have the unilateral ability to regulate
foreign-based online pharmacies that sell medications to consumers within
their borders. Similarly, international regulations fall short because they are
too focused on education and short-term relief. Accordingly, consumers
are not being protected, and a more comprehensive and cohesive international
approach is necessary to prevent the proliferation of an epidemic that has
already killed thousands of people.
Before addressing the purpose for which this article was written—to
recommend a solution to the problems associated with certain online
pharmacies via the implementation of a comprehensive international
regulatory regime—the arguments against such a recommendation must
be noted.
First, there is an argument that, although illicit online pharmacies have
destroyed or greatly harmed people’s lives, these same pharmacies have
also saved lives. For example, an American woman named Nina spoke
out after the United States government shut down numerous illicit online
pharmacies.234 Nina had become dependent upon a particular illegal
online pharmacy after she lost her health insurance and could no longer
afford to obtain a prescription through conventional means.235 Instead, she

233. See Karberg, supra note 15, at 142.
234. Thomas Ginsberg, Online Drug Bust is Casting a Wide Net[:] Some Customers
with Valid Medical Needs Were Using the Internet Pharmacy. Experts Say Battling Sites
Will Be Hard, PHILA. INQUIRER (Apr. 22, 2005), http://articles.philly.com/2005-04-22/news/
254269851internet-pharmacy-online-pharmacy-internet-site.
235. Id.
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paid $45 a month for medication she obtained online.236 Completely
oblivious to the source of the medication, who operated the site, and who
utilized the site, Nina was unfazed—“[i]t was that or nothing.”237
Second, there is an argument against regulation due to the principle of
customer autonomy.238 As the argument goes, consumers should have the
opportunity to decide for themselves where they obtain their medications
without governmental interference on behalf of the public good.239 Further,
“[b]y allowing the market to control prices, free from excessive government
interference, the result will be cheaper drugs for those who can least afford
it.”240
This argument is particularly powerful coming from the elderly,
impoverished, uninsured, and underinsured who may not be able to see a
doctor or otherwise obtain the drugs.241 The argument for customer autonomy
is also strong for people who want privacy with respect to the (embarrassing)
drugs they wish to obtain.242
Third, there is an argument that attempts to regulate would only unduly
burden legitimate online pharmacies and would not affect the troublesome
pharmacies.243 Regulators are therefore cautioned to tailor their regulatory
schemes to address the problematic types of pharmacies and be wary not
to cast too wide of a net that will place obstacles in the way of legitimate
online pharmacies.244 In fact, it has been suggested that governments
should allow the natural forces of the online market to establish standards
rather than establishing their own,245 or focus instead on reducing the
demand for pharmaceuticals.246
Lastly, it has been argued that the problems associated with the lack of
a physician-patient relationship, a driving force being the call for
236. Id.
237. Id. The fear that regulating online pharmacies may prevent people like Nina
from obtaining the prescription medication they need is significantly weakened, at least in
the United States, by the implementation of the Affordable Care Act. Regardless of the
ultimate wisdom of the Act, “[m]ore than 16 million people have gained health insurance”
under it, suggesting that people seeking prescription drugs for legitimate medical purposes
may have another option besides resorting to illicit online pharmacies and, therefore, will
not be negatively affected by regulating online pharmacies. See Administration: 16M
gained health coverage under ObamaCare, THE HILL, (Mar. 16, 2015) http://thehill.com/
policy/healthcare/235819-administration-16-million-people-gained-obamacare-coverage.
238. See Lipman, supra note 32, at 562.
239. See id.
240. Alexander, supra note 39.
241. See id.; see also Liang & Mackey, supra note 94, at 130.
242. See Alexander, supra note 39.
243. Williams, supra note 13, at 187.
244. Id.
245. See Carlini, supra note 29, at 161.
246. Castronova, supra note 19, at 221.
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increased regulation, is misplaced because similar practices occur at
traditional brick-and-mortar pharmacies.247 Such critics contest that
doctors prescribing medicine without a face-to-face interaction is not as
anomalous an occurrence as those pushing for regulation postulate.248 For
example, many doctors at some point in their career have filled a prescription
for a close friend or a family member of a longtime patient without actually
seeing that person.249 Accordingly, those who resist regulating online
pharmacies accuse doctors who do criticize the practice of issuing prescription
medications online without face-to-face consultation of engaging in
“professional protectionism.”250
Notwithstanding these arguments to the contrary, the rationale for more
regulation—particularly where targeted at abusive practices—is more
compelling. Ingestion of erroneous or improper dosages can be an issue
of life or death. Furthermore, stopping the proliferation of illegitimate
online pharmacies would curb the irresponsible use of prescription
medicines. The responsible use of medicine, including proper identification
and dosage, could lead to global annual savings of up to $500 billion
dollars annually.251 Such consumer protection should be a legitimate
concern for governments across the world.252
Recognizing the problem and the need to address it is not enough, as
additional issues arise in deciding how to effectively solve the problem.
What type of international or multinational regulatory regime is appropriate
and necessary to address this worldwide problem? What type of regulatory
regime should be implemented?
VI. MULTINATIONAL REGULATORY SCHEME
Many scholars and commentators agree that the solution to the problems
associated with some online pharmacies must involve international
cooperation.253 For example, the WHO Coordinator of IMPACT, Dr.
247. Mills, supra note 22, at 15 n.68.
248. Id.
249. See id.
250. See id.
251. See INTERNATIONAL PHARMACEUTICAL FEDERATION, https://www.fip.org (last
visited Jan. 17, 2014).
252. See Liang, supra note 93, at 312–14.
253. See, e.g., Hochberg, supra note 21, at 445; Gomez, supra note 104, at 462; Rost,
supra note 24, at 1335; Lipman, supra note 32, at 564–65; Yoo, supra note 9, at 86;
Williams, supra note 13, at 185.
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Valerio Reggie, stated, “we need to coordinate action at a global level.”254
Scholars and other commentators are not short on giving this same
advice.255 For instance, one scholar noted, “[i]n both the short and long
term, emphasis should be upon compacts, agreements, and accords among
nations and between federal and state governments inter se.”256 In addition
to calling for government cooperation, at least one scholar calls for a
strategy that incentivizes private corporations to cooperate as well.257
It is clear that the market for illicit pharmaceutical distribution “does
not respect international lines and hence, neither can efforts to eliminate
it.”258 However, a multilateral international compact that transforms the
successes and failures of the Ryan Haight Act into a cohesive and unified
approach to regulating online pharmacies will effectively give sovereign
States an opportunity to fill the previously incurable extraterritorial
deficiencies in local regulation and provide consumers with the protection
they need.
VII. INTERNATIONAL COMPACT
Ryan Haight became the face of online pharmacy reform in the United
States. The United States legislation enacted in response to his story
contains a workable framework for an international compact that
addresses online pharmacy abuse. The Ryan Haight Act provides the
content for a compact not only in its text, but also in that which critical
analysis and hindsight reveal are missing from its text.
To begin, an international compact based upon the Ryan Haight Act
(and other approaches to combating online pharmacies) should create a
uniform body of law that is applicable to all online pharmacies operating
within the borders of any country that is a signatory to the compact. The
goal of the compact should be to protect consumers in the global marketplace,
which will be accomplished through the multilateral enforcement of the
compact’s provisions.259

254. WHO and Partners Accelerate Fight Against Counterfeit Medicines, supra note
55.
255. See Williams, supra note 13, at 185.
256. Id.
257. Lipman, supra note 32, at 568 (calling for governments to incentivize “payment
intermediaries, search engines, and other private actors” to do their part).
258. Liang, supra note 93, at 313–14.
259. Effective enforcement of the compact may be most readily obtainable if each
signatory incorporates the provisions of the compact into its domestic law, consistent with
its state practice, through either “self-executing” means or by implementing additional
domestic legislation. See International Norms and Standards Relating to Disability,
UNITED NATIONS ENABLE, (2003–2004) http://www.un.org/esa/socdev/enable/comp101.htm
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The drafters of the compact must be mindful of how the compact will
affect the different types of online pharmacies. With this in mind, the
compact should greatly emphasize reducing prescription medications that
are distributed from rogue online pharmacies. This is a feat that has been
largely unobtainable to date, and the Ryan Haight Act did not effectuate
real change in this regard either.260 In addition, the compact should target
prescribing-based sites, and will feasibly be successful in eradicating such
sites, just as the Ryan Haight Act did. Traditional online pharmacies
should be subject to certain compliance measures, but should be the least
emphasized of the three types of online pharmacies.
Moving to a more particularized view of the content the compact should
contain, the underlying standard for the compact should be very similar to
that of the Ryan Haight Act, but with a scope beyond “controlled
substances.” The broadened scope should embrace all prescription
medications distributed online. Thus, the standard should make it illegal
to “knowingly or intentionally . . . deliver, distribute, or dispense” any
prescription medications online, or to “aid or abet” such activity, unless
the activity is performed in accordance with the compact.261 To comply
with the compact, online pharmacies should at least be required to perform
the following compliance measures: 1) register, 2) disclose information,
3) report information, and 4) require at least one doctor-patient in person
examination.
First, online pharmacies should be required to register with their
respective governments, just as the Ryan Haight Act requires registration
with the DEA in the United States.262 This registration requirement should
be in place for any online pharmacy regardless of whether or not it
dispenses medications known in the United States as “controlled substances.”
Furthermore, a list of all registered pharmacies should be kept on a central
server that is maintained by, and is available to, all signatories. This
registration requirement will serve many purposes. It will both aid in
recognizing (and eliminating) noncompliant online pharmacies and will
educate signatories’ citizens about which online pharmacies are operating
legitimately.263 For guidance on registration and maintaining such a
(discussing the ways in which international treaty law may be incorporated into domestic
law).
260. See Lipman, supra note 32, at 554.
261. See 21 U.S.C. § 841(h)(1) (2010).
262. See 21 U.S.C. §§ 823(f), 841(h)(1) (2010).
263. Karberg, supra note 15, at 125.
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database, drafters of the compact may look to the NABP VIPPS program.
However, whereas some criticize the NABP’s VIPPS program for its
voluntary nature,264 this compact’s registration requirement should be
mandatory for all online pharmacies operating in a State that is a signatory.
Second, pharmacies must be required to display certain information on
their websites, just as provided in the Ryan Haight Act.265 The Ryan
Haight Act provides a meaningful list of the type of information that
should be disclosed, and the drafters of the compact should emulate such
provisions. Further, if such information is properly displayed on an online
pharmacy’s website, and the website has effectively registered with its
respective government, a “seal of approval” should be issued for the site
to display. This will give consumers further indication that the site they
are ordering prescription medications from is operating legitimately.
Third, online pharmacies should be required to submit reports to their
respective governments, similar to the Ryan Haight Act’s reporting
provision. 266 The precise drugs and the quantity offered may be decided
at a later date. There should be two triggers for mandatory reporting:
surpassing a total volume of prescription medications dispensed, and
surpassing a certain amount of “dangerous” substances dispensed.
“Dangerous” substances would be those that provide some of the effects
that the Mayo Clinic has identified as the causes of “prescription drug
abuse,” including getting high, relaxing, and feeding an addiction.267
Drugs such as Vicodin, Oxycodone, Hydrocodone, Xanax, Adderall, Viagra,
and Codeine should be included in such a category.268
The “dangerous” substance data submissions should also be utilized to
maintain a database similar to California’s Controlled Substance
Utilization Review and Evaluation System (“CURES”), which makes
information about the quantity of controlled substances a patient has
previously purchased available to physicians and pharmacists.269 The
international compact should require its signatories to maintain such a
database and, contrary to the CURES operation, make it mandatory for
264. Yoo, supra note 9, at 69.
265. See 21 U.S.C. § 831(a).
266. See 21 U.S.C. § 827(d); 21 U.S.C. § 827(e); 21 U.S.C. § 827(h).
267. See Mayo Clinic Staff, Prescription Drug Abuse, MAYO CLINIC (Dec. 5, 2014),
http://www.mayoclinic.com/health/prescription-drug-abuse/DS01079/DSECTION=causes.
268. Commonly Abused Prescription Drugs Chart, NATIONAL INSTITUTE ON DRUG
A BUSE (Sept. 2002), http://www.drugabuse.gov/drugs-abuse/commonly-abused-drugs/
commonly-abused-prescription-drugs-chart (providing a detailed list of drugs that could
constitute such a list).
269. Office of the Attorney General, Controlled Substance Utilization Review and
Evaluation System (CURES), California Prescription Drug Monitoring Program, STATE
OF CALIFORNIA DEPARTMENT OF JUSTICE, http://oag.ca.gov/cures-pdmp (last visited
Jan.17, 2014).
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physicians and pharmacists to inquire into the amount of “dangerous”
substances a potential online customer has previously acquired to help
determine the validity and medical necessity of the request.270
Fourth, registered online pharmacies should be banned from dispensing
prescription medications without first being presented with a prescription
that is based upon an in-person doctor-patient examination, just as the
Ryan Haight Act does.271 The language of the Ryan Haight Act’s similar
provision should be emulated here as well, including language that allows
for “covering physician” prescriptions to be issued.272
In addition to establishing these compliance provisions, there should be
both criminal and civil penalties implemented for violating the compact.
There should be penalties not only for the operator of a noncomplying
pharmacy, but also for the individual knowingly purchasing materials from a
noncomplying pharmacy. This will deter illicit activities and broaden the
scope of responsibility. There should also be a framework in place
facilitating communication and cooperation among signatories to enforce
these penalties.
In addition to the Ryan Haight Act, prior international actions should
be incorporated into the compact as well. Signatories should be required
to promote existing educational campaigns, including the proliferation of
the WHO’s Medical Products and the Internet: A Guide to Finding
Reliable Information. For instance, all online pharmacies registered to
operate under the compact should be required to include a link to such
information (and other similar materials) on their websites. Additionally,
signatories should be required to support INTERPOL’s enforcement
operation, Operation Pangea, if not already doing so.
Aside from the content of the compact, its adoption, proliferation, and
enforcement should be discussed. While all States should be welcome to
be a signatory, States with large numbers of online pharmacy consumers
should be targeted to become signatories, because they have the greatest
need for consumer protection.

270. See Robert Glatter M.D., Fighting Prescription Drug Abuse With a National
Database, FORBES (Feb. 16, 2012, 12:46 PM), http://www.forbes.com/sites/robertglatter/
2012/02/16/fighting-prescription-drug-abuse-a-national-online-database-2/ (calling for a
national database, similar to the CURES system, that is mandatory for physicians and
pharmacists).
271. See 21 U.S.C. § 829(e)(2)(A).
272. Id.
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The United States should be at the forefront of promoting the proliferation
of the compact. As the United States’ domestic regulation forms the basis
for the compact, it only makes sense that the United States should promote
the new international standard based thereon. Therefore, the United States
should be the first to adopt the compact and show to the rest of the world
its intellectual honesty in trying to solve this problem. The United States
should call upon its allies and biggest trade partners to become signatories
as well.
Aside from the United States acting to promote the adoption of the
compact, international organizations like the WHO, IMPACT, and the IHC
should promote its adoption as well. These are particularly well-suited
avenues through which the compact should be promoted. This is critical
because the potential impact of the compact increases as the number of
signatories increases.
Lastly, such an international compact is feasible and enforceable. Consumers
participating in the online pharmacy market make their purchases from
within the borders of a nation state. Similarly, the products they purchase
are imported into that nation State. Therefore, signatories have two
distinct points at which they can enforce the compact: purchase and
importation. For instance, signatories may seize the items imported or
enforce the illegality of the purchase as outlined by the compact. Further,
the registration requirement allows signatories to enforce the provisions
of the compact against any unregistered or noncompliant site, even if the
site is based in another country, provided that country is also a signatory
to the compact.
VIII. CONCLUSION
Online pharmacies can be a powerful resource for consumers in an
increasingly technological and fast paced global economy. However, the
challenges they present must be dealt with by means of a unified stance
against their fraudulent operation. This can, and should, be achieved in
the form of an international compact as described above. The Ryan Haight
Act was a tremendous step forward not only for the United States, but also
for the global community. However, unilateral domestic regulations,
though successful on some level, are inherently inadequate to address the
core of the problem. The unintended consequence of the Ryan Haight Act
is that it can serve as a framework by which the international community
can formulate its own regulatory scheme to combat illicit online pharmacies.
“Love you, Mom.”273 Ryan Haight’s mother should have had the
opportunity to hear her son say these words many more times than she
273.
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did. Now, she says, “I wish that something could be done so that no one
has to go through this.”274 The aforementioned international compact is
that something.

274. Drugs and the Internet: A Deadly Combination, DRUG ENFORCEMENT AGENCY,
http://www.justice.gov/dea/prevention/francine-interview.shtml (last visited Jan. 17, 2014).
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